Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/TMDX
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

TransMedics Group Inc (TMDX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

TransMedics Group (TMDX) trades at $88.27, down 1.9% over 24 hours, with a bullish technical signal from moving averages but mixed earnings performance. The company reported strong 2025 revenue of $605.49M and net income of $190.29M, though 2026 projections show margin pressure. Recent news highlights investigations into fiduciary duties by directors, alongside positive coverage of growth initiatives in kidney transplantation and European expansion.
The outlook is cautiously optimistic, supported by analyst consensus favoring Buy ratings and a $99.57 price target, implying potential upside. Key risks include ongoing legal scrutiny, execution challenges from heavy investments, and declining profit margins. Investors should weigh robust revenue growth against these headwinds for balanced decision-making.
Read full analysis

Key Stats

  • Market Cap
    $3.06B
  • Volume
    -
  • Sector
    Technology
  • 52W High
    $150.42
  • 52W Low
    $61.99
  • Typical Hold Time
    -
  • Enterprise Value
    $3.46B
  • Div Yield
    -
  • Trading Activity
    -
$87.5
52W Low: $61.99
14 May 2026
52W High: $150.42
01 Dec 2025

Track TransMedics Group Inc (TMDX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, TransMedics Group Inc has traded between a low of $61.99 and a high of $150.42, highlighting its annual price range. Buy and sell TransMedics Group Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Most Recent News

Content is generated by Aura AI

Dyne Therapeutics falls 16% after Novartis DM1 trial failure raises doubts on RNA therapy success

Dyne Therapeutics' stock dropped 16% following Novartis' failure in a DM1 clinical trial, which increased concerns about the effectiveness of RNA-targeting therapies for muscle diseases. This setback challenges the potential of Dyne's lead drug, z-ro...

Market News
4 hours ago
Seeking Alpha
Bearish
news icon
Dyne Therapeutics falls 16% after Novartis DM1 trial failure raises doubts on RNA therapy success

Northern Graphite appeals Quebec's suspension of its Lac des Iles mining lease over financial guarantee dispute

Northern Graphite Corporation has filed an appeal against Quebec's decision to suspend its Lac des Iles graphite mine lease due to a disagreement over a financial guarantee payment for site restoration. The company argues it is not in default and the...

Market News
4 hours ago
Newsfile Corp
Bearish
news icon
Northern Graphite appeals Quebec's suspension of its Lac des Iles mining lease over financial guarantee dispute

CanCambria CEO to discuss European natural gas opportunities at World Energies Summit 2026

CanCambria Energy's CEO, Dr. Paul R. Clarke, will join a panel at the World Energies Summit 2026 in London to discuss upstream exploration and development in Europe and the Eastern Mediterranean. The panel will focus on energy security, resource deve...

Market News
4 hours ago
Newsfile Corp
Bullish
news icon
CanCambria CEO to discuss European natural gas opportunities at World Energies Summit 2026
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $3.06B
  • Volume
    -
  • Sector
    Technology
  • 52W High
    $150.42
  • 52W Low
    $61.99
  • Typical Hold Time
    -
  • Enterprise Value
    $3.46B
  • Div Yield
    -
  • Trading Activity
    -
$87.5
52W Low: $61.99
14 May 2026
52W High: $150.42
01 Dec 2025

Track TransMedics Group Inc (TMDX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, TransMedics Group Inc has traded between a low of $61.99 and a high of $150.42, highlighting its annual price range. Buy and sell TransMedics Group Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!